(Q48733867)

15 February 2018

title

IDH1 mutation is associated with seizures and protoplasmic subtype in patients with low-grade gliomas. (English)

1 reference

15 February 2018

author

Giovanna Marisa D'abaco

2

1 reference

15 February 2018

Alexandra Gorelik

7

1 reference

15 February 2018

Terence J O'Brien

9

1 reference

15 February 2018

Andrew H. Kaye

10

1 reference

15 February 2018

Andrew Morokoff

object named as

Andrew P Morokoff

11

0 references

Cameron Nowell

object named as

Cameron J Nowell

6

0 references

author name string

Simon V Liubinas

1

1 reference

15 February 2018

Bradford M Moffat

3

1 reference

15 February 2018

Michael Gonzales

4

1 reference

15 February 2018

Frank Feleppa

5

1 reference

15 February 2018

Katharine J Drummond

8

1 reference

15 February 2018

publication date

5 June 2014

1 reference

15 February 2018

published in

Epilepsia

1 reference

15 February 2018

volume

55

1 reference

15 February 2018

issue

9

1 reference

15 February 2018

page(s)

1438-1443

1 reference

15 February 2018

The pathogenesis of tumour associated epilepsy

cites work

1 reference

Isocitrate dehydrogenase mutations in diffuse gliomas: clinical and aetiological implications.

21 January 2018

1 reference

Analysis of the IDH1 codon 132 mutation in brain tumors

21 January 2018

1 reference

Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas

21 January 2018

1 reference

IDH1 mutations are present in the majority of common adult gliomas but rare in primary glioblastomas

21 January 2018

1 reference

IDH1 and IDH2 mutations in gliomas

21 January 2018

1 reference

Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas.

21 January 2018

1 reference

IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas

21 January 2018

1 reference

Molecular predictors of progression-free and overall survival in patients with newly diagnosed glioblastoma: a prospective translational study of the German Glioma Network

21 January 2018

1 reference

IDH1 mutations in low-grade astrocytomas predict survival but not response to temozolomide

21 January 2018

1 reference

A role for glutamate in growth and invasion of primary brain tumors

21 January 2018

1 reference

Brain tumors and epilepsy: pathophysiology of peritumoral changes

21 January 2018

1 reference

Glutamate release by primary brain tumors induces epileptic activity

21 January 2018

1 reference

Glutamate is associated with a higher risk of seizures in patients with gliomas.

21 January 2018

1 reference

Cancer-associated IDH1 mutations produce 2-hydroxyglutarate

21 January 2018

1 reference

IDH1/2 mutations in WHO grade II astrocytomas associated with localization and seizure as the initial symptom.

21 January 2018

1 reference

Fiji: an open-source platform for biological-image analysis

21 January 2018

1 reference

Primary brain tumours in adults.

21 January 2018

1 reference

Low-grade gliomas of chronic epilepsy: a distinct clinical and pathological entity.

21 January 2018

1 reference

An integrated genomic analysis of human glioblastoma multiforme

21 January 2018

1 reference

Metabolism unhinged: IDH mutations in cancer.

21 January 2018

1 reference

IDH1 and IDH2 hotspot mutations are not found in canine glioma.

21 January 2018

1 reference

IDH1 mutations in gliomas: when an enzyme loses its grip

21 January 2018

1 reference

Magnetic resonance metabolic imaging of glioma.

21 January 2018

1 reference

Decreased expression of the active subunit of the cystine/glutamate antiporter xCT is associated with loss of heterozygosity of 1p in oligodendroglial tumours WHO grade II.

21 January 2018

1 reference

Baseline levels of glucose metabolites, glutamate and glycerol in malignant glioma assessed by stereotactic microdialysis

21 January 2018

1 reference

The excitatory amino acid transporter-2 induces apoptosis and decreases glioma growth in vitro and in vivo

21 January 2018

1 reference

Ion channels and amino acid transporters support the growth and invasion of primary brain tumors.

21 January 2018

1 reference

Profiling the effects of isocitrate dehydrogenase 1 and 2 mutations on the cellular metabolome

21 January 2018

1 reference

NMDA receptor activation and respiratory chain complex V inhibition contribute to neurodegeneration in d-2-hydroxyglutaric aciduria

21 January 2018

1 reference

D-2-hydroxyglutaric aciduria: further clinical delineation.

21 January 2018

1 reference

MR imaging characteristics of protoplasmic astrocytomas.

21 January 2018

1 reference

Expression of EAAT2 in neurons and protoplasmic astrocytes during human cortical development

21 January 2018

1 reference

Do astrocytes contribute to excitation underlying seizures?

21 January 2018

1 reference

NG2 cells: Properties, progeny and origin

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/EPI.12662

1 reference

15 February 2018

PubMed ID

24903073

1 reference

15 February 2018